Cancer Research
Modified T Cells Show Promise Against Childhood Blood Cancers in NCI Trial
Researchers modified children's own immune cells to fight B-cell leukemia and lymphoma when standard treatments failed.
Clinical Trial
Mar 28, 2026 0
Results for "Thymus Regeneration" in Cancer
20 articles
Cancer Research
Strength Training Fights Inflammaging in Bone Marrow Transplant Survivors
A 10-week supervised strength program targets chronic inflammation and self-efficacy in long-term allogeneic HCT survivors.
Clinical Trial
May 25, 2026 0
Cancer Research
Engineered T Cells Show Promise Against Deadly Mesothelioma Cancer
Small trial tests modified immune cells injected directly into chest cavity to fight aggressive cancer with 12-month survival rate.
Clinical Trial
Mar 28, 2026 1
Cancer Research
Brain Cancer Trial Uses Patient's Own Tumor Cells to Train Immune System
Innovative immunotherapy approach converts patient tumor cells into personalized vaccines to fight aggressive brain cancer.
Clinical Trial
Mar 28, 2026 0
Cancer Research
Engineered Immune Cells Show Promise Against Advanced Cancer in Early Trial
Scientists modified patients' immune cells to better recognize and attack cancer tumors expressing NY-ESO-1 protein.
Clinical Trial
Mar 28, 2026 0
Cancer Research
Turin Study Maps Why Multiple Myeloma Escapes Anti-CD38 Immunotherapy
Italian researchers track genomic and cellular changes in myeloma patients to uncover why anti-CD38 treatments stop working.
Clinical Trial
Jun 16, 2026 0
Cancer Research
Engineered T Cells Show Promise Against Childhood Cancers in Phase I Trial
Modified immune cells targeting GD2 protein demonstrated safety in treating aggressive childhood cancers like neuroblastoma and osteosarcoma.
Clinical Trial
Mar 28, 2026 0
Cancer Research
CAR T-Cell Therapy Shows Promise Against Relapsed Blood Cancers in Small Trial
Engineered immune cells target CD19+ cancer cells in patients with treatment-resistant lymphoma and leukemia.
Clinical Trial
Mar 28, 2026 1
Cancer Research
CAR-T Cell Therapy Shows Promise for Treatment-Resistant Blood Cancers
Small trial tests innovative immune cell therapy for patients with relapsed non-Hodgkin's lymphoma who failed standard treatments.
Clinical Trial
Mar 28, 2026 0
Cancer Research
Whole-Cell Breast Cancer Vaccine Plus PD-1 Inhibitor Targets Treatment-Resistant Metastatic Disease
A phase I/II trial tests SV-BR-1-GM, a whole-cell cancer vaccine, combined with the checkpoint inhibitor retifanlimab in patients with metastatic breast cancer.
Clinical Trial
May 29, 2026 0
Cancer Research
Enhanced CAR-T Cell Therapy Shows Promise Against Treatment-Resistant Blood Cancers
Modified immune cells engineered to overcome cancer's defenses completed safety testing in lymphoma patients.
Clinical Trial
Mar 29, 2026 12
Cancer Research
New Cancer Immunotherapy IBI346 Shows Promise in Multiple Myeloma Trial
Small trial tests innovative treatment IBI346 for blood cancer patients who didn't respond to standard therapies.
Clinical Trial
Mar 28, 2026 1
Cancer Research
CAR-T Cell Therapy Shows Promise Against Treatment-Resistant Multiple Myeloma
Genetically modified immune cells target blood cancer that stopped responding to standard treatments in 28-patient trial.
Clinical Trial
Mar 28, 2026 0
Cancer Research
Spinal Delivery of Rituximab Tested for Brain and Spine Lymphoma Involvement
MD Anderson's Phase 1/2 trial explored injecting rituximab directly into spinal fluid to target CNS lymphoid malignancies.
Clinical Trial
Jun 16, 2026 0
Cancer Research
CD226 Immune Receptor Explored as Predictor of Immunotherapy Response in Advanced Liver Cancer
A French trial investigated whether circulating immune cell profiles, specifically CD226 expression, could predict who responds to Atezolizumab/Bevacizumab in advanced HCC.
Clinical Trial
Jun 9, 2026 0
Cancer Research
T-VEC Plus Pembrolizumab Tested in Melanoma After Anti-PD-1 Failure
Phase 2 trial explores whether combining oncolytic virus therapy with immunotherapy can rescue patients whose melanoma progressed on PD-1 blockade.
Clinical Trial
May 29, 2026 0
Cancer Research
New Cancer Drug NKTR-255 Shows Promise in Blood Cancer Treatment Trial
Phase 1 trial tests innovative immunotherapy for multiple myeloma and lymphoma patients who didn't respond to standard treatments.
Clinical Trial
Mar 29, 2026 1
Cancer Research
Triple Combination Cancer Immunotherapy Shows Promise in Advanced Solid Tumors
Small trial tests novel three-drug approach combining immune checkpoint inhibitor, vaccine, and inflammation blocker for metastatic cancers.
Clinical Trial
Mar 29, 2026 1
Cancer Research
High-Dose Radiation Therapy Study Reveals Immune System Response Patterns in Cancer
Researchers tracked immune changes during intensive radiation treatment to optimize cancer therapy and potential immunotherapy combinations.
Clinical Trial
Mar 28, 2026 2
Cancer Research
Natural Killer Cell Therapy Shows Promise for Advanced Cancer Treatment
Autologous NK cell therapy combined with immunotherapy tested in 27 patients with treatment-resistant cancers.
Clinical Trial
Mar 29, 2026 0
Page 1 of 2Next